{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:25:46Z","timestamp":1794475546917,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2021Y9151"],"award-info":[{"award-number":["2021Y9151"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Department of Health","award":["2020CXB026"],"award-info":[{"award-number":["2020CXB026"]}]},{"DOI":"10.13039\/100016078","name":"Fuzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022-S-088"],"award-info":[{"award-number":["2022-S-088"]}],"id":[{"id":"10.13039\/100016078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56656-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:46:37Z","timestamp":1781199997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metrnl ameliorates ulcerative colitis by inhibiting NLRP3 inflammasome activation via ASC"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruilong","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"56656_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","volume":"20","author":"MF Neurath","year":"2019","unstructured":"Neurath, M. F. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat. Immunol. 20, 970\u2013979 (2019).","journal-title":"Nat. Immunol."},{"key":"56656_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros, B. & Kaplan, G. G. Ulcerative colitis in adults: a review. JAMA 330, 951\u2013965 (2023).","journal-title":"JAMA"},{"key":"56656_CR3","doi-asserted-by":"crossref","unstructured":"Gajendran, M. et al. A comprehensive review and update on ulcerative colitis. Dis. Mon. 65, 100851 (2019).","DOI":"10.1016\/j.disamonth.2019.02.004"},{"key":"56656_CR4","doi-asserted-by":"crossref","unstructured":"Sun, Y., Zhang, Z., Zheng, C. Q. & Sang L. X. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J. Gastroenterol. 27, 2963\u20132978 (2021).","DOI":"10.3748\/wjg.v27.i22.2963"},{"key":"56656_CR5","doi-asserted-by":"crossref","unstructured":"Zuo, L. et al. The adipokine Metrnl ameliorates chronic colitis in Il-10-\/- mice by attenuating mesenteric adipose tissue lesions during spontaneous colitis. J. Crohns Colitis 13, 931\u2013941 (2019).","DOI":"10.1093\/ecco-jcc\/jjz001"},{"key":"56656_CR6","doi-asserted-by":"crossref","unstructured":"Ushach, I. et al. Meteorin-like\/Meteorin-\u03b2 is a novel immunoregulatory cytokine associated with inflammation. J. Immunol. 201, 3669\u20133676 (2018).","DOI":"10.4049\/jimmunol.1800435"},{"key":"56656_CR7","doi-asserted-by":"crossref","unstructured":"Gholamrezayi, A. et al. Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines. Lipids Health Dis. 19, 230 (2020).","DOI":"10.1186\/s12944-020-01404-6"},{"key":"56656_CR8","doi-asserted-by":"crossref","unstructured":"Li, Z. Y. et al. Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides. Acta Pharmacol. Sin. 37, 1458\u20131466 (2016).","DOI":"10.1038\/aps.2016.70"},{"key":"56656_CR9","doi-asserted-by":"crossref","unstructured":"Kim, Y. Y. et al. Meteorin regulates mesendoderm development by enhancing nodal expression. PLoS One 9, e88811 (2014).","DOI":"10.1371\/journal.pone.0088811"},{"key":"56656_CR10","first-page":"e47073","volume":"15","author":"E Onat","year":"2023","unstructured":"Onat, E., Kocaman, N. & Balta, H. The role of meteorin-like peptide and Asprosin in colon carcinoma. Cureus 15, e47073 (2023).","journal-title":"Cureus"},{"key":"56656_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.diabres.2019.02.026","volume":"150","author":"HM El-Ashmawy","year":"2019","unstructured":"El-Ashmawy, H. M., Selim, F. O., Hosny, T. A. M. & Almassry, H. N. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis. Diabetes Res. Clin. Pract. 150, 57\u201363 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"56656_CR12","doi-asserted-by":"crossref","unstructured":"Xue, J. C. et al. Natural products modulate NLRP3 in ulcerative colitis. Front. Pharmacol. 14, 1265825 (2023).","DOI":"10.3389\/fphar.2023.1265825"},{"key":"56656_CR13","doi-asserted-by":"crossref","unstructured":"Lv, Q. et al. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation. Acta Pharm. Sin. B 11, 2880\u20132899 (2021).","DOI":"10.1016\/j.apsb.2021.03.011"},{"key":"56656_CR14","doi-asserted-by":"crossref","unstructured":"Liao, L. Z. et al. NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging. Aging (Albany NY) 13, 20534\u201320551 (2021).","DOI":"10.18632\/aging.203435"},{"key":"56656_CR15","doi-asserted-by":"crossref","unstructured":"Lin, C., Jiang, Z., Cao, L., Zou, H. & Zhu X. Role of NLRP3 inflammasome in systemic sclerosis. Arthritis Res. Ther. 24, 196 (2022).","DOI":"10.1186\/s13075-022-02889-5"},{"key":"56656_CR16","doi-asserted-by":"publisher","first-page":"155002","DOI":"10.1016\/j.phymed.2023.155002","volume":"119","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Salvianolic acid B inhibits atherosclerosis and TNF-\u03b1-induced inflammation by regulating NF-\u03baB\/NLRP3 signaling pathway. Phytomedicine 119, 155002 (2023).","journal-title":"Phytomedicine"},{"key":"56656_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/ptr.7686","volume":"37","author":"MH Ri","year":"2023","unstructured":"Ri, M. H. et al. Narirutin exerts anti-inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages. Phytother Res. 37, 1293\u20131308 (2023).","journal-title":"Phytother Res."},{"key":"56656_CR18","doi-asserted-by":"publisher","first-page":"24270","DOI":"10.18632\/aging.202143","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Yu, P. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway. Aging (Albany NY). 12, 24270\u201324287 (2020).","journal-title":"Aging (Albany NY)"},{"key":"56656_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12967-023-04313-1","volume":"21","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS\/Cl- efflux signaling pathway. J. Transl. Med. 21, 452 (2023).","journal-title":"J. Transl Med."},{"key":"56656_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cns.12219","volume":"20","author":"ZY Li","year":"2014","unstructured":"Li, Z. Y. et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci. Ther. 20, 344\u2013354 (2014).","journal-title":"CNS Neurosci. Ther."},{"key":"56656_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.diabres.2017.10.005","volume":"135","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes. Diabetes Res. Clin. Pract. 135, 7\u201310 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"56656_CR22","doi-asserted-by":"publisher","first-page":"e0204180","DOI":"10.1371\/journal.pone.0204180","volume":"13","author":"M Dadmanesh","year":"2018","unstructured":"Dadmanesh, M., Aghajani, H., Fadaei, R. & Ghorban, K. Lower serum levels of Meteorin-like\/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PLoS One. 13, e0204180 (2018).","journal-title":"PLoS One"},{"key":"56656_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.diabres.2017.11.031","volume":"136","author":"HS Chung","year":"2018","unstructured":"Chung, H. S. et al. Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes. Diabetes Res. Clin. Pract. 136, 100\u2013107 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"56656_CR24","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.12659\/MSM.915331","volume":"25","author":"K Wang","year":"2019","unstructured":"Wang, K. et al. Serum levels of Meteorin-like (Metrnl) are increased in patients with newly diagnosed type 2 diabetes mellitus and are associated with insulin resistance. Med. Sci. Monit. 25, 2337\u20132343 (2019).","journal-title":"Med. Sci. Monit."},{"key":"56656_CR25","doi-asserted-by":"crossref","unstructured":"Hu, C. et al. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway. Redox Biol. 31, 101747 (2020).","DOI":"10.1016\/j.redox.2020.101747"},{"key":"56656_CR26","doi-asserted-by":"crossref","unstructured":"Kerget, B., Af\u015fin, D. E., Kerget, F., A\u015fk\u0131n, S. & Akg\u00fcn M. Is Metrnl an adipokine involved in the anti-inflammatory response to acute exacerbations of COPD?. Lung 198, 307\u2013314 (2020).","DOI":"10.1007\/s00408-020-00327-4"},{"key":"56656_CR27","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.924564","volume":"26","author":"L Xu","year":"2020","unstructured":"Xu, L., Cai, Y., Wang, Y. & Xu, C. Meteorin-like (METRNL) attenuates myocardial ischemia\/reperfusion injury-induced cardiomyocytes apoptosis by alleviating endoplasmic reticulum stress via activation of AMPK-PAK2 signaling in H9C2 cells. Med. Sci. Monit. 26, e924564 (2020).","journal-title":"Med. Sci. Monit."},{"key":"56656_CR28","doi-asserted-by":"crossref","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M. & Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13, 148\u2013159 (2016).","DOI":"10.1038\/cmi.2015.95"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56656-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56656-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56656-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:04:56Z","timestamp":1786111496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56656-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56656-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of The First Affiliated Hospital of Fujian Medical University and conducted in accordance with the US National Institute of Health Guide for Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24518"}}